• Submitted matched HiRise and MDCT patient scans meeting all required performance criteria
• Submitted further validation data and updated instructions for use to vendor
• Awaiting vendor team's review and conclusion of validation process

CurveBeam AI Limited (ASX: CVB) has provided an update on the timeline for completing validation of the enhanced HiRise™ for a key vendor's robotics surgical system. The Company has submitted matched HiRise and MDCT patient scans which met all required performance criteria, with HiRise™ images meeting or exceeding the MDCT metrics that were used as 'control'. The Company has also submitted to the vendor further validation data and substantive accompanying documents, including updated instructions for use to include HiRise™. The Company is confident this submission meets the requirements to complete validation and awaits the vendor team's review and its conclusion. The Company will advise the market when it has a further update. Greg Brown, CEO & Managing Director of CurveBeam AI, commented that there is a mutual interest to advance this project as quickly as possible for both parties, and the Company looks forward to updating the market as further feedback is received.